An observational study to characterize chronic wounds in patients with diabetic foot ulcers (DFUs) - Multimodal characterization of DFUs

Centre for Human Drug Research0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年6月11日

试验速览

暂无简介。

•Eligible patients must meet all of the following inclusion criteria at
•1. Male and female patients with ischemic or neuro-ischemic DFUs, >=18 years of
•2. Type 1 or type 2 diabetes mellitus with either oral hypoglycaemic medication
•and/or insulin treatment. Any other clinical significant active or uncontrolled
•chronic disease than diabetes mellitus will be recorded.
•3. Suitable DFU(s) for performing assessments as judged by the investigator or
•medically qualified designee.
•4. Planned to receive PTA by standard care practice protocol.
•5. Willing to give written informed consent and willing and able to comply with
•the study protocol.
•Healthy volunteers
•Eligible gender, age, BMI, and ethnicity-matched healthy subjects must meet all
•of the following inclusion criteria at screening:
•1. Healthy subjects, male or female, >=18 years of age. The health status is
•verified by absence of evidence of any clinical significant active or
•uncontrolled chronic disease following a detailed medical history and a
•complete physical examination including vital signs. In the case of uncertain
•or questionable results, tests performed during screening may be repeated
•before randomization to confirm eligibility or judged to be clinically
•irrelevant for healthy subjects.
•2. Willing to give written informed consent and willing and able to comply with
•the study protocol.

•Eligible patients will be excluded if any of the following exclusion criteria
•apply at screening:
•1. Presence of wounds other than non-healing amputation wounds or DFUs (e.g.
•due to trauma, ingrown toenails, or tophaceous gout).
•2. Have any current and/or recurrent pathologically relevant skin or vascular
•condition other than chronic vascular insufficiency.
•3. Any (medical) condition that would, in the opinion of the investigator,
•potentially compromise the safety or compliance of the subject or may preclude
•the subject*s successful completion of the clinical trial.
•Healthy volunteers
•Eligible gender, age, BMI, and ethnicity-matched healthy subjects will be
•excluded if any of the following exclusion criteria apply at screening:
•1. Presence of wounds on legs or feet.
•2. Have any current and/or recurrent pathologically relevant skin or vascular
•3. Participation in an investigational drug or device study within 3 months
•prior to screening or more than 4 times a year.
•4. Use of topical medication (prescription or over-the-counter (OTC)) within 30
•days of the start of the study in local treatment area (legs and feet).
•5. Any (medical) condition that would, in the opinion of the investigator,
•potentially compromise the safety or compliance of the subject or may preclude
•the subject*s successful completion of the clinical trial.

发起方